Patents Assigned to Georgia State University Research Foundation
-
Patent number: 12280047Abstract: The present invention provides methods for detecting and/or treating a subject having an aneurysm or at risk for developing an aneurysm. It has been discovered that a key metabolite of the kynurenine (Kyn) pathway, a major route for the metabolism of essential amino acid tryptophan (Trp) into nicotinamide adenine dinucleotide (NAD+), plays a critical role in the formation of aneurysms, for example abdominal aortic aneurysms. In particular, it has been discovered that 3-Hydroxyanthranilic acid (3-HAA), a product of kynureninase (KYNU), plays a causative role in the formation of aneurysms by, for example exerting pro-inflammatory effects on vascular smooth muscle cells. It has further been discovered that elevated levels of 3-HAA are indicative of the presence and/or progression of an aneurysm, and 3-HAA levels correlate with the size (aortic diameter) of the aneurysm.Type: GrantFiled: July 4, 2022Date of Patent: April 22, 2025Assignee: Georgia State University Research Foundation, Inc.Inventor: Ming-Hui Zou
-
Patent number: 12220393Abstract: Embodiments of the present invention relate generally the use of compositions comprising a glutathione precursor and a selenium source, e.g., compositions which elevate intracellular glutathione, in the prevention and treatment of Zika viral diseases, e.g., Zika fever. Related embodiments are directed to use of such compositions, e.g., compositions comprising a glutathione precursor and a selenium source, in reducing the infectivity of Zika viruses or Zika viral particles.Type: GrantFiled: May 1, 2018Date of Patent: February 11, 2025Assignees: ProImmune Company LLC, Georgia State University Research FoundationInventors: Albert Crum, Julia Hilliard
-
Publication number: 20250011292Abstract: Novel rhodanine derivatives and methods for their use are provided herein. The rhodanine derivatives are useful in treating or preventing viral infections, including coronavirus infections (e.g., a SARS-CoV-2 virus infection). The rhodanine derivatives are also useful as photosensitizers for photodynamic therapy in treating or preventing cancer in a subject.Type: ApplicationFiled: October 12, 2022Publication date: January 9, 2025Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Binghe WANG, Xiaoxiao Yang, Ming Luo, Mukesh Kumar
-
Patent number: 12179214Abstract: Described herein are technologies for concentrating rare-earth elements from a heavy fraction of grit in gangue produced in kaolin mining. In some examples, grit is separated as a non-clay fraction of gangue produced in a kaolin mining operation. The grit is separated into a heavy mineral grit sub-fraction and a light mineral grit sub-fraction. Rare-earth elements, particularly heavy rare-earth elements, are thereafter extracted from the heavy mineral grit sub-fraction using various extraction technologies.Type: GrantFiled: June 17, 2020Date of Patent: December 31, 2024Assignees: Georgia State University Research Foundation, Thiele Kaolin CompanyInventors: W. Crawford Elliott, Daniel Joseph Gardner, Ed Riley, Prakash Malla
-
Patent number: 12175367Abstract: Embodiments of the present systems and methods may provide improved capability to predict the risk of recurrence of ductal carcinoma in situ (DCIS) conditions using whole slide image analysis based on machine learning techniques. For example, in an embodiment, a computer-implemented method for determining treatment of a patient may comprise receiving an image of living tissue of a patient, annotating the entire image into tissue structures, extracting texture features from the annotated image, determining a distribution of the extracted texture features relative to tissue conditions, classifying the patient into a risk group based on the distribution, and treating the patient accordingly based on the risk group.Type: GrantFiled: December 16, 2019Date of Patent: December 24, 2024Assignee: Georgia State University Research Foundation, Inc.Inventors: Sergey Klimov, Yi Jiang, Arkadiusz Gertych
-
Publication number: 20240391886Abstract: The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.Type: ApplicationFiled: July 11, 2024Publication date: November 28, 2024Applicant: Georgia State University Research Foundation, Inc.Inventors: Binghe Wang, Xingyue Ji, Ladie Kimberly De La Cruz, Xiaoxiao Yang
-
Patent number: 12091432Abstract: The present disclosure is concerned with compounds, compositions, and methods for synthesizing sphingosines and glycolipids including glycosphingolipids, such as but not limited to lactosyl sphingosine.Type: GrantFiled: February 22, 2022Date of Patent: September 17, 2024Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Lei Li, George Peng Wang, Madhusudhan Reddy Gadi, Jun Yin
-
Patent number: 12071415Abstract: The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.Type: GrantFiled: April 16, 2021Date of Patent: August 27, 2024Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Binghe Wang, Xingyue Ji, Ladie Kimberly de la Cruz, Xiaoxiao Yang
-
Patent number: 12037466Abstract: Compositions and methods of making a culture medium from a polymeric material are described herein. The method can include (a) depolymerizing and/or dispersing the polymeric material to obtain a depolymerized and/or dispersed residue, and (b) combining the depolymerized and/or dispersed residue with one or more adjuvants to form a culture medium. In some embodiments, the polymeric material can be a plastic article, such as a waste carpet material. Culture media prepared from the compositions and methods are also described. The culture media are suitable for culturing microorganisms including bacterium, algae, and fungus. The microorganisms can be used to produce a bioproduct such as a biopolymer, an enzyme, or a cellular metabolite.Type: GrantFiled: November 2, 2020Date of Patent: July 16, 2024Assignee: Georgia State University Research Foundation, Inc.Inventors: Bryan Stubblefield, Eric Gilbert
-
Patent number: 12016863Abstract: Disclosed herein are compounds having antiviral activity, and, in particular, an inhibitory activity on the replication of Respiratory Syncytial Virus (RSV). Druggable target sites, including Px, in the RSV N protein are disclosed, as well as compounds targeting Px. The compounds can be used to treat patients with RSV infection.Type: GrantFiled: May 3, 2019Date of Patent: June 25, 2024Assignees: Georgia State University Research Foundation, Inc., Emory UniversityInventors: Richard Plemper, Julien Sourimant, Edgars Jecs, Dennis Liotta, Stephen Pelly, Robert Wilson, Zackery Will Dentmon
-
Patent number: 11884961Abstract: Provided herein are DNA-glycan conjugates that include a glycan and a covalently attached polynucleotide. The polynucleotide includes a plurality of modules. Each module includes a nucleotide string, and the plurality of modules includes a monomer module that corresponds to each carbohydrate monomer present in the DNA-glycan conjugate, and a linkage module that corresponds to each glycosidic linkage present between each carbohydrate monomer in the DNA-glycan conjugate. The nucleotide sequence of the plurality of modules corresponds to the glycan structure. Also provided herein are methods for making and using the DNA-glycan conjugates. Further provided is a computer-implemented method for translating data from a nucleotide sequence to a glycan structure, a system for converting data from a glycan structure to a nucleotide sequence, and a system for translating data from a nucleotide sequence to a glycan structure.Type: GrantFiled: June 1, 2018Date of Patent: January 30, 2024Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Peng George Wang, Jing Song, Muhammed Shukkoor Kondengaden, Aishwarya Parameswaran
-
Patent number: 11801299Abstract: The compositions and methods are described for generating an immune response to a hepatitis B virus. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens for generating a protective immune response to a hepatitis B virus, in the subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat an infection caused by hepatitis B virus.Type: GrantFiled: July 6, 2021Date of Patent: October 31, 2023Assignee: Georgia State University Research Foundation, Inc.Inventors: Farshad Guirakhoo, Arban Domi, Nathanael P. McCurley, Rahul Basu, Ming Luo
-
Patent number: 11738098Abstract: Embodiments of the present disclosure provide for contrast agents, methods of making contrast agents, and methods of using contrast agents, and the like.Type: GrantFiled: October 12, 2020Date of Patent: August 29, 2023Assignee: Georgia State University Research Foundation, Inc.Inventors: Jenny Jie Yang, Zhiren Liu, Jie Jiang, Shenghui Xue, Jinjuan Qiao, Mani Salarian
-
Patent number: 11717551Abstract: Disclosed are compositions comprising Rhamnus prinoides (GESHO) extract or fragments thereof and methods of using Gesho extract for the inhibition of biofilm formation.Type: GrantFiled: May 7, 2019Date of Patent: August 8, 2023Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Mariya Campbell, Eric Gilbert
-
Patent number: 11708320Abstract: The present invention provides processes for the synthesis of organic azides, intermediates for the production thereof, and compositions related thereto.Type: GrantFiled: June 28, 2019Date of Patent: July 25, 2023Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventor: Hao Xu
-
Patent number: 11685711Abstract: The present invention generally relates to carbon monoxide releasing compounds and compositions, and their use as carbon monoxide prodrugs.Type: GrantFiled: August 9, 2018Date of Patent: June 27, 2023Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Ladie Kimberly c. De La Cruz, Xingyue Ji, Zhixiang Pan, Binghe Wang
-
Publication number: 20230105108Abstract: Compounds and methods for use to treat a bacterial infection caused by, for example, gram positive bacteria, gram negative bacteria, and/or mycobacteria are provided herein. Also provided herein are compounds and methods for use in potentiating the effect of an antibiotic in the treatment of a bacterial infection. Pharmaceutical compositions including the compounds as described herein are also provided.Type: ApplicationFiled: December 18, 2020Publication date: April 6, 2023Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Binghe WANG, David W. BOYKIN, Arvind KUMAR, Mengyuan ZHU, Manjusha ROY CHOUDHURY, Bingchen YU
-
Patent number: 11607458Abstract: Disclosed herein is a chemical delivery system having: i) a cargo compound comprising a first reactive moiety covalently bonded to a first enrichment moiety and a tethered cargo moiety, wherein the first reactive moiety is bonded to the tethered cargo moiety via a cleavable linker; and ii) a trigger compound comprising a second reactive moiety covalently bonded to a second enrichment moiety and a cargo-releasing moiety. The first enrichment moiety and the second enrichment moiety cause an increase in concentration of the cargo compound and the concentration of the trigger compound at a target site, causing a bimolecular reaction between the first reactive moiety and the second reactive moiety to form a cyclization precursor compound. The cargo moiety is then released from the cyclization precursor compound in a unimolecular cyclization reaction. Methods for treating conditions such as cancer, inflammatory conditions, and infections with the chemical delivery systems are also described.Type: GrantFiled: October 25, 2018Date of Patent: March 21, 2023Assignee: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: Binghe Wang, Yueqin Zheng, Xingyue Ji, Robert Emuobonuvie Aghoghovbia
-
Patent number: 11597845Abstract: A coating for conversion of formaldehyde to carbon dioxide includes an alcohol/aldehyde oxidase and a formate oxidase immobilized on a solid particulate support; and a latex binder.Type: GrantFiled: June 29, 2018Date of Patent: March 7, 2023Assignees: DOW GLOBAL TECHNOLOGIES LLC, ROHM AND HAAS COMPANY, GEORGIA TECH RESEARCH CORPORATION, GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: John Anderson Roper, III, Sudhakar Balijepalli, Paul Doll, Andreas S. Bommarius, Christopher W. Jones, Christopher R. Murdock, John M. Robbins, Akihiro Nomura, Bettina R. Bommarius, Adam Holewinski, Giovanni Gadda
-
Patent number: 11576609Abstract: The present disclosure relates to noninvasive methods for detecting liver fibrosis. Disclosed herein are noninvasive liver fibrosis detection methods that use Doppler Ultrasound devices and a physics-based machine learning method. Further disclosed herein are methods for detecting liver fibrosis in a subject by detecting and measuring the presence of a shift in the frequency of blood flow in the hepatic vein as compared to the frequency of blood flow in the portal vein.Type: GrantFiled: June 29, 2018Date of Patent: February 14, 2023Assignee: Georgia State University Research Foundation, Inc.Inventors: Yi Jiang, Hao Chen, Bin Zhang, Sergey Klimov